Skip to main content
. 2002 Mar;76(5):2567–2572. doi: 10.1128/jvi.76.5.2567-2572.2002

FIG. 2.

FIG. 2.

NP418-426 variant epitope specificity of CTL clones. Target cells (BLCL) were incubated overnight with 5 μM concentrations of the HLA-B*3501-restricted NP418-426 epitope variants, namely, NP418-426/1980 (▿), NP418-426/1972 (□), and NP418-426/1957 (⧫), or were left untreated (•) and used as a negative control. Clones 1972-1 (A), 1980-2 (B), and 1980-4 (C), obtained from different donors, were added at different effector-to-target cell ratios, and specific lysis was calculated. The results, given as the percent specific lysis (mean ± standard deviation), are representative of multiple assays.